IL6 and ulcerative colitis: Moreover, we found that FLCWK significantly inhibited IL-6 and STAT3 mRNA expression in a rat model of ulcerative colitis, which may provide a theoretical pharmacodynamic basis for the enhancement of 5-FU efficacy in CRC by suppressing the IL-6/STAT3 pathway.